RxDoctor Payments Data

Jan Parrillo, MD

Family Medicine · Orlando, FLNPI 1275500951

Payments from drug & device makers

$8,696in general payments, 2019–2025

Across 442 payments — averaging $19.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • Novo Nordisk$1K
  • Tosoh Bioscience, Inc.$941
  • Astellas Pharma US Inc$844
  • Lilly USA, LLC$441
  • Daiichi Sankyo Inc.$382
  • plus $4K from 52 others

What the payments were for

  • Food & beverage$7,45786%
  • Education$2983%
  • Gifts$94111%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca66$1,293
Novo Nordisk66$1,222
Tosoh Bioscience, Inc.1$941
Astellas Pharma US Inc45$844
Lilly USA, LLC28$441
Daiichi Sankyo Inc.20$382
Pfizer23$371
AbbVie(2 entities)21$365
Esperion Therapeutics, Inc.11$210
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC11$184
Johnson & Johnson11$173
Amgen11$169
Merck11$148
Kowa Pharmaceuticals America, Inc.8$141
Takeda Pharmaceuticals U.S.A., Inc.8$137
Biohaven Pharmaceutical Holding Company Ltd.8$123
GSK8$123
Noven Therapeutics, LLC6$112
Boehringer Ingelheim7$107
Phathom Pharmaceuticals, Inc.6$92
Amarin Pharma, Inc.4$83
Sanofi Pasteur Inc.5$73
Bayer4$67
Exact Sciences3$59
Vistapharm, Inc.4$56
Abbott3$52
Genentech USA, Inc.3$48
Eisai Inc.3$47
Sanofi-aventis U.S. LLC3$43
Renalytix AI, Inc.2$41
Xeris Pharmaceuticals, Inc.2$36
Radius Health, Inc.2$35
Scilex Pharmaceuticals Inc.2$35
Averitas Pharma Inc.1$29
Mylan Specialty L.p.2$28
Inspire Medical Systems, Inc.1$27
Silk Road Medical, Inc.1$25
Biohaven Pharmaceuticals, Inc.1$24
Alk-abello, Inc1$22
Jazz Pharmaceuticals Inc.1$19
Medtronic1$18
Hikma Pharmaceuticals USA1$18
Teva Pharmaceuticals USA, Inc.1$18
Dynavax Technologies Corporation1$17
IBSA Pharma Inc.1$17
Shield Therapeutics Inc1$16
Seqirus USA Inc1$16
Hologic Sales And Service, LLC1$16
Agios Pharmaceuticals, Inc.1$15
Noven Pharmaceuticals, Inc.1$15
Idorsia Pharmaceuticals US Inc1$14
Gilead1$13
Aytu Biopharma, Inc.1$13
Endo Pharmaceuticals Inc.1$13
E.r. Squibb & Sons, L.L.C.1$13
Shire North American Group Inc1$13
Boston Scientific1$13
Stimwave Technologies Incorporated1$9

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,696 in reported general payments places this provider in the 90th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$395,355
Medicare patients
633
Services billed
14,681

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban86$89,885
OzempicSemaglutide70$79,411
MounjaroTirzepatide52$67,699
Trelegy ElliptaFluticasone/Umeclidin/Vilanter55$44,882
JanuviaSitagliptin Phosphate21$33,038
JardianceEmpagliflozin15$25,277
Spiriva RespimatTiotropium Bromide23$19,524
MyrbetriqMirabegron18$18,299
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr16$11,083
SymbicortBudesonide/Formoterol Fumarate20$11,023
Combivent RespimatIpratropium/Albuterol Sulfate18$8,883
Atorvastatin Calcium845$7,010
Levothyroxine Sodium548$6,147
TradjentaLinagliptin11$5,550
SynthroidLevothyroxine Sodium72$4,754

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$371$89,88586 claims
Novo NordiskOzempic$1,222$79,41170 claims
Lilly USA, LLCMounjaro$441$67,69952 claims
Boehringer IngelheimJardiance, Spiriva Respimat, Combivent Respimat, Tradjenta$107$59,23467 claims
GSKTrelegy Ellipta, Anoro Ellipta$123$55,96471 claims
MerckJanuvia$148$33,03821 claims
Astellas Pharma US IncMyrbetriq$844$18,29918 claims
AstraZenecaSymbicort$1,293$11,02320 claims
AbbVieSynthroid$365$4,75472 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Orlando

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →